Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata
NCT07757867Completed
- Sponsor
- Tanta University
- Start
- Oct 2022
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Randomised trial of cetirizine and latanoprost in alopecia areata (4 arms), sponsored by Tanta University. Primary endpoint: Severity of Alopecia Tool at 12 weeks. Started Oct 2022; status: completed.
02
Drugs
cetirizinelatanoprost
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07757867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07757867.